Serum endostatin levels in patients with hepatocellular carcinoma.
Yamagata
M
M
Shiratori
Y
Y
Dan
Y
Y
Shiina
S
S
Takayama
T
T
Makuuchi
M
M
Omata
M
M
D000704:Analysis of Variance; D020533:Angiogenesis Inhibitors / Q000097:blood* / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000097:blood* / Q000628:therapy; D003094:Collagen / Q000097:blood* / Q000627:therapeutic use; D043169:Endostatins; D016228:Endothelial Growth Factors / Q000097:blood; D006801:Humans; D008103:Liver Cirrhosis / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood*; D008222:Lymphokines / Q000097:blood; D009367:Neoplasm Staging; D010446:Peptide Fragments / Q000097:blood* / Q000627:therapeutic use; D012016:Reference Values; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D043169:Endostatins; D016228:Endothelial Growth Factors; D008222:Lymphokines; D010446:Peptide Fragments; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D003094:Collagen